Clinical Trial Update: Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA

View source ↗

Summary

This clinical trial is evaluating whether longitudinal minimal residual disease monitoring using ctDNA can predict hepatocellular carcinoma recurrence after cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Zhujiang Hospital | Conditions: Hepatocellular Carcinoma Resectable | Status: RECRUITING